Role of replacement therapy in the evaluation of thrombosis occurring in congenital bleeding conditions

Role of replacement therapy in the evaluation of thrombosis occurring in congenital bleeding conditions -

[1]  Wenman Wu,et al.  Paradoxical bleeding and thrombotic episodes of dysprothrombinaemia due to a homozygous Arg382His mutation , 2016, Thrombosis and Haemostasis.

[2]  A. Lombardi,et al.  Pulmonary embolism in congenital bleeding disorders: intriguing discrepancies among different clotting factors deficiencies , 2016, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[3]  P. Simioni,et al.  New Prothrombin Mutation (Arg596Trp, Prothrombin Padua 2) Associated With Venous Thromboembolism , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[4]  H. Kiyoi,et al.  The first case of antithrombin-resistant prothrombin Belgrade mutation in Japanese , 2016, Annals of Hematology.

[5]  D. Radojkovic,et al.  A novel prothrombin mutation in two families with prominent thrombophilia – the first cases of antithrombin resistance in a Caucasian population , 2013, Journal of thrombosis and haemostasis : JTH.

[6]  Y. Miyawaki.  Thrombosis from a prothrombin mutation conveying antithrombin resistance , 2013 .

[7]  A. Girolami,et al.  Congenital FVII deficiency and thrombotic events after replacement therapy , 2011, Journal of Thrombosis and Thrombolysis.

[8]  A. Girolami,et al.  Associated prothrombotic conditions are probably responsible for the occurrence of thrombosis in almost all patients with congenital FVII deficiency. Critical review of the literature , 2009, Journal of Thrombosis and Thrombolysis.

[9]  S. Schulte,et al.  Biochemical comparison of seven commercially available prothrombin complex concentrates , 2008, International journal of clinical practice.

[10]  C. Samama.  Prothrombin complex concentrates: a brief review , 2008, European journal of anaesthesiology.

[11]  P. Mannucci,et al.  Molecular and functional characterization of a natural homozygous Arg67His mutation in the prothrombin gene of a patient with a severe procoagulant defect contrasting with a mild hemorrhagic phenotype. , 2002, Blood.

[12]  A. O'marcaigh,et al.  Genetic analysis and functional characterization of prothrombins Corpus Christi (Arg382-Cys), Dhahran (Arg271-His), and hypoprothrombinemia. , 1996, Blood.

[13]  J. Lusher,et al.  Thrombogenicity associated with factor IX complex concentrates. , 1991, Seminars in hematology.

[14]  K. Mann,et al.  Identification of a congenital dysthrombin, thrombin Quick. , 1980, The Journal of clinical investigation.